Global Business News
October 1, 2026
Business Briefing Markets · Companies · Technology · Economy · Finance
Latest News
Independent business intelligence Global markets, companies and ideas shaping business.

Most powerful obesity drug yet: People lost up to 25% of weight in trial

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Most powerful obesity drug yet: People lost up to 25% of weight in trial

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.

Original reporting
Ars Technica
Read Original Report →